Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium. Show more
Rue Edouard Belin 12, Mont-Saint-Guibert, 1435, Belgium
Market Cap
157.9M
52 Wk Range
$1.26 - $8.59
Previous Close
$1.58
Open
$1.58
Volume
1,497,175
Day Range
$1.58 - $1.70
Enterprise Value
172.5M
Cash
25.93M
Avg Qtr Burn
-21.56M
Insider Ownership
16.18%
Institutional Own.
9.52%
Qtr Updated
03/31/26
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|